Peter from Malaysia

Registered at the short selling broker Kriptomat, 4 minutes ago.

» Try Kriptomat you too
Don't show again

Provention Bio, Inc. (PRVB) shares information

Provention Bio Inc


24h Change

-3.23 %

PRVB

Live rate: Market closed

Stock data per Friday 15 Jan, 2021

PRVB
NASDAQ/NGS (GLOBAL SELECT MARKET)
15.5
15.46
15.00
-0.5 (-3.23%)
US Market is closed

Live Stock price in graph for Provention Bio Inc (PRVB)

  • Latest Volume

    2,517,586 (-57.22 %)

  • Volume prev. day

    5,884,305

  • Avg. daily volume

    1,029,071

  • Market cap

    847,318,365

  • P/E ratio

    n/a

  • Today high

    15.89 USD

  • Today low

    14.65 USD

  • 52 week high

    19.45 USD

  • 52 week low

    5.42 USD

  • YTD Change

    n/a

Quick links

 

Latest news about Provention Bio Inc

Below you can find the most recent news posts about Provention Bio Inc, primarily from US and UK based news sources.

Provention Bio Announces Pricing of $100 Million Public Offering of Common Stock

Thursday, 14 January 2021, 01:03:00
RED BANK, N.J., Jan. 13, 2021 /PRNewswire/ — Provention Bio, Inc. (Nasdaq: PRVB), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, today announced the pricing of its previously announced underwritten public offering of 6,250,000 shares of its…
— PR Newswire


The Daily Biotech Pulse: Bausch Health Issues Positive Pre-Announcement, Acorda Streamlines Operations

Wednesday, 13 January 2021, 13:25:38
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 12) AbbVie Inc (NYSE: ABBV ) AcelRx Pharmaceuticals Inc (NASDAQ: ACRX ) Aldeyra Therapeutics Inc (NASDAQ: ALDX ) Alkermes Plc (NASDAQ: ALKS ) AtriCure Inc. (NASDAQ: ATRC ) Bioanalytical Systems, Inc. (NASDAQ: BASI ) BIOLASE Inc (NASDAQ: BIOL ) (announced an agreement to expand laser adoption and hands-on training programs in targeted geographies) CareDx Inc (NASDAQ: CDNA ) Celsius Holdings, Inc. (NASDAQ: CELH ) DermTech Inc (NASDAQ: DMTK ) Dyne Therapeutics Inc (NASDAQ: DYN ) Edap Tms SA (NASDAQ: EDAP ) Evelo Biosciences Inc (NASDAQ: EVLO ) EXACT Sciences Corporation (NASDAQ: EXAS ) Eyenovia Inc (NASDAQ: EYEN ) Genetron Holdings Ltd – ADR (NASDAQ: GTH ) Guardant Health Inc (NASDAQ: GH ) (reacted to presentation at the JPMorgan Healthcare Conference) Intra-Cellular Therapies Inc (NASDAQ: ITCI ) Kaleido Biosciences Inc (NASDAQ: KLDO ) Laboratory Corp.
— Benzinga


Provention Bio Announces Proposed Public Offering of Common Stock

Tuesday, 12 January 2021, 22:26:00
RED BANK, N.J., Jan. 12, 2021 /PRNewswire/ — Provention Bio, Inc. (Nasdaq: PRVB), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, today announced that it has commenced an underwritten public offering of 6,000,000 shares of its common stock….
— PR Newswire


Provention Bio to Participate in the H.C. Wainwright Virtual BioConnect Conference

Wednesday, 6 January 2021, 22:05:00
RED BANK, N.J., Jan. 6, 2021 /PRNewswire/ — Provention Bio, Inc. (Nasdaq: PRVB), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today announced that management will participate in a fireside chat presentation at the H.C. Wainwright…
— PR Newswire


Provention Bio Announces U.S. FDA Filing of a Biologics License Application (BLA) and Priority Review for Teplizumab for the Delay or Prevention of Clinical Type 1 Diabetes in At-risk Individuals

Monday, 4 January 2021, 13:00:00
RED BANK, N.J., Jan. 4, 2021 /PRNewswire/ — Provention Bio, Inc. (Nasdaq: PRVB), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today announced that the Biologics License Application (BLA) for teplizumab for the delay or prevention of…
— PR Newswire


Trading broker recommendation

We recommend that you check out Capital.com as they have a very good selection of stocks available for both going short and long.

Rating: 9.57/10
Minimum deposit: €200
Description: Capital.com offer a large number of stocks for trading. Register an account today and check if they have PRVB available or trade one of the many other CFD stocks they have.
Risk warning: 75% of retail investor accounts lose money when trading CFDs with Capital.